JooYeon Lee1, Dong Il Gwon2, Gi-Young Ko1, Jong Woo Kim1, Kyu-Bo Sung1. 1. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea. 2. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea. radgwon@amc.seoul.kr.
Abstract
OBJECTIVES: To investigate the radiologic and histological characteristics of biliary intraductal metastasis of advanced gastric cancer and the clinical outcomes of percutaneous, metallic stent placement. MATERIALS AND METHODS: We retrospectively assessed 24 patients with obstructive jaundice related to biliary intraductal metastasis of gastric cancers who underwent PTBD and subsequent metallic stent placement between 2003 and 2012. RESULTS: Intraductal metastases appeared as uniform, concentric, linear (n = 17) or band-like (n = 7), enhanced wall thickening on CT, and 20 patients (83.3 %) had cystic ductal lesions. On pathology specimens, malignant cells scattered in the submucosal layer caused a desmoplastic reaction. The technical and clinical success rate of stent placement was achieved in all 24 patients. The median survival time was 203 days. Stent occlusion was observed in four patients with 49-278 days following stent placement. The median stent patency time was 156 days. CONCLUSIONS: The radiologic and histological characteristics of biliary intraductal metastasis of advanced gastric cancer consist of uniform, linear or band-like, enhanced biliary wall thickening and malignant cells scattered in the submucosal layer, together with the desmoplastic reaction without any disruption of the epithelial layer. Uncovered metallic stent placement was also a safe and effective method of palliative treatment in these patients. KEY POINTS: • The CT findings of intraductal metastasis were linear/band-like, enhanced biliary wall thickening. • The histological finding was malignant cells scattered in the submucosal layer. • It showed a desmoplastic reaction without any disruption of the epithelial layer. • Uncovered metallic stent placement was a safe and effective palliative treatment.
OBJECTIVES: To investigate the radiologic and histological characteristics of biliary intraductal metastasis of advanced gastric cancer and the clinical outcomes of percutaneous, metallic stent placement. MATERIALS AND METHODS: We retrospectively assessed 24 patients with obstructive jaundice related to biliary intraductal metastasis of gastric cancers who underwent PTBD and subsequent metallic stent placement between 2003 and 2012. RESULTS: Intraductal metastases appeared as uniform, concentric, linear (n = 17) or band-like (n = 7), enhanced wall thickening on CT, and 20 patients (83.3 %) had cystic ductal lesions. On pathology specimens, malignant cells scattered in the submucosal layer caused a desmoplastic reaction. The technical and clinical success rate of stent placement was achieved in all 24 patients. The median survival time was 203 days. Stent occlusion was observed in four patients with 49-278 days following stent placement. The median stent patency time was 156 days. CONCLUSIONS: The radiologic and histological characteristics of biliary intraductal metastasis of advanced gastric cancer consist of uniform, linear or band-like, enhanced biliary wall thickening and malignant cells scattered in the submucosal layer, together with the desmoplastic reaction without any disruption of the epithelial layer. Uncovered metallic stent placement was also a safe and effective method of palliative treatment in these patients. KEY POINTS: • The CT findings of intraductal metastasis were linear/band-like, enhanced biliary wall thickening. • The histological finding was malignant cells scattered in the submucosal layer. • It showed a desmoplastic reaction without any disruption of the epithelial layer. • Uncovered metallic stent placement was a safe and effective palliative treatment.
Authors: Yoon Jin Lee; Se Hyung Kim; Jae Young Lee; Min A Kim; Jeong Min Lee; Joon Koo Han; Byung Ihn Choi Journal: AJR Am J Roentgenol Date: 2009-10 Impact factor: 3.959
Authors: Jason N Rogart; Ara Boghos; Federico Rossi; Hashem Al-Hashem; Uzma D Siddiqui; Priya Jamidar; Harry Aslanian Journal: Gastrointest Endosc Date: 2008-06-17 Impact factor: 9.427
Authors: J Lammer; K A Hausegger; F Flückiger; F W Winkelbauer; R Wildling; G E Klein; S A Thurnher; L Havelec Journal: Radiology Date: 1996-10 Impact factor: 11.105
Authors: T C Tham; D L Carr-Locke; J Vandervoort; R C Wong; D R Lichtenstein; J Van Dam; F Ruymann; S Chow; J J Bosco; T Qaseem; D Howell; D Pleskow; W Vannerman; E D Libby Journal: Gut Date: 1998-05 Impact factor: 23.059
Authors: G E Kim; H S Shin; J S Seong; J J Loh; C O Suh; J T Lee; J K Roh; B S Kim; W H Kim; M W Kim Journal: Int J Radiat Oncol Biol Phys Date: 1994-02-01 Impact factor: 7.038
Authors: Jung Gu Park; Gyoo-Sik Jung; Jong Hyouk Yun; Byung Chul Yun; Sang Uk Lee; Byung Hoon Han; Ji Ho Ko Journal: Eur Radiol Date: 2017-03-27 Impact factor: 5.315